Cyberknife Market

Report Overview

According to a recent report by Market.us, the Global Cyberknife Market size is expected to be worth around USD 1,417 Million by 2032 from USD 780 Million in 2022, growing at a CAGR of 12.3% during the forecast period from 2023 to 2032.

Cyberknife is a stereotactic radiosurgery system (SRS, an advanced radiosurgery that uses a robotic arm to deliver high doses of targeted radiation to destroy tumors or lesions, ensuring painless, non-invasive treatment. Cyberknife is the most developed technology globally and is very beneficial compared to the proton radiation treatment.

This technology treats tumors across the body, mainly in the prostate, brain, spine, head, lung, neck, liver, kidney, and pancreas. Increasing demand for minimally invasive procedures, rising cancer incidences, and several product launches are key factors driving the market growth of the Cyberknife market. Reasons such as decreasing physical activity, increasing use of unhealthy diets, and high tobacco and alcohol consumption are the reasons for increasing cancer occurrence.

Key Takeaways

• CyberKnife Market Growth: Since 2004, the CyberKnife market has experienced steady expansion due to advances in radiation therapy technology as well as rising cancer cases that require radiotherapy treatment.
• Radiation Therapy: The CyberKnife is used primarily for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), providing highly targeted radiation delivery directly into tumors.
• CyberKnife Offers Non-Invasive Therapy Options: One key advantage of CyberKnife lies in its non-invasive nature; patients don’t require surgery and this results in reduced side effects and quicker recover times for themselves and other individuals undergoing therapy with CyberKnife.
• Image-Guided Radiation Therapy (IGRT): CyberKnife’s Image Guided Radiotherapy System provides real-time imaging and tracking capabilities, enabling precise tumor targeting during treatment as it moves due to breathing or other bodily functions. IGRT therapy may prove especially valuable in treating rapidly moving tumors that evade treatment due to respiratory or other bodily functions.
• Cancer Treatment: CyberKnife’s main application lies in cancer therapy for various forms, such as brain tumors, lung cancer and prostate cancer. As it provides minimally invasive and highly effective care options, CyberKnife stands out as an ideal treatment option.

Product Analysis

The Body Cyberknife Segment is the Most Lucrative in the Global Cyberknife Market

Based on product, the market for cyberknife is segmented into head Cyberknife and body Cyberknife. Among these product types, the body Cyberknife segment is the most lucrative in the global cyberknife market. Owing to mainly rising breast cancer incidence in the market in the cyberknife. Also, head Cyberknife use in the market is increasing fast in the forecast period.

Application Analysis

The cancer Segment is Estimated to be the Most Lucrative Segment

By application, the market is further divided into vascular malformation, cancer, tumor, and other applications. The cancer segment is estimated to be the most lucrative segment in the global cyberknife market. It is owing to the increase of cancer incidence of diseases that infect many individuals worldwide. Furthermore, prostate, lung, bronchus, and colorectal are the main five cancers in the united states.

The increasing incidence of cancer patient population pool worldwide directly increases the cyberknife market globally. Vascular malformation will show the highest market growth in the forecast period owing to its efficiency and advantages compared to other segments. Also, it uses non-surgical and less invasive technology, targeting only specific parts needed for treatment. This procedure uses using most developed technology compared to other segments.

End-User Analysis

Hospital Segment is Estimated to be the Most Lucrative Segment

Based on end-user, the market is segmented into radiotherapy centers, hospitals, clinics, and ambulatory surgical centers. Among these end-users, the hospital segment is estimated to be the most lucrative segment in the global cyberknife market, with the largest revenue share of 43% and a projected increase with a high CAGR during the forecast period.

Owing to its increasing number of patients and skilled expert in the cyberknife market are the main reasons for the increasing global market. Also, the ambulatory surgical center is expected to increase with high market growth in the forecast period. It is owing to its low waiting time and low cost for the treatment.

Key Market Segments

Based on Product

• Head Cyberknife
• Body Cyberknife

Based on Application

• Vascular Malformation
• Cancer
• Tumor
• Others Application

Based on End-User

• Radiotherapy Centers
• Hospitals
• Clinics
• Ambulatory Surgical Center
• Other End Users

Drivers

The Increasing Presence of Several Cancer Types Is Driving The Market Growth.

The global cyberknife market is growing at a high rate. This is mainly due to the increasing number of different cancer types, which are throat cancer, lung cancer, spine cancer, prostate cancer, pancreas cancer, liver cancer, and others. Also, increasing technology in the market, such as a non-invasive or less invasive technique for surgery, is helping the market grow.

The rising geriatric population in the market will further advance the market growth. Furthermore, less time hospital stays, fast recovery, and low cost than other surgery are increasing the market growth and will grow in the forecast period.

Hence, the procedure efficiently treats cancer and helps the market grow. Moreover, this procedure helps to decrease the spread of the market. Advanced precision is very high at the time of the surgery of the tumor with Cyberknife, which has low damage to the body’s tissue and structure near the tumor region.

Restraints

Lack of expert professionals

Not many individuals know about this type of technology in the market. Furthermore, there are a low number of professionals who are experts in such types of surgeries. Fewer individuals are not accepting new technology for fear of malfunction.

Opportunity

Demand for Advanced Technological Development is Increasing and Further Helping the Market Growth.

Advanced technology development in the market is needed to develop the technology further to help the market grow in the forecast period. Technology development can help to adapt the less invasive or non-invasive surgery method, which anticipates the market’s growth. Several government initiatives are helping the market growth, which will help to propel the market in the forecast period.

Increasing drives for awareness growth for individuals across the globe are increasing at a fast rate. Government initiatives are taken to develop the market by government agencies further. Furthermore, fast technology development is done by several additional market players for market growth in the forecast period with large investments in the industry.

Trends

Smoking Popularity is Increasing Across the Globe

The development of new technology in the market and the creation of new instruments are helping the market grow as new industry trends. Smoking popularity is increasing across the globe, which will lead to market growth across the globe. Adaption of Cyberknife technology is increasing in the market at a very high rate.

Regional Analysis

North America Is Estimated To Be The Most Lucrative Market During The Forecasted Period.

In 2022, North America dominated the market with the largest market share of 43%. Owing to the rising prevalence of chronic diseases, less invasive surgeries, painless surgeries, and reduced surgery time because of cyberknife surgeries. In the unites states, radiation facilities are increasing at a high rate of 16.7% in the market.

APAC is expected to grow at the largest rate in the forecast period. The growing geriatric population infected with chronic disorders, increasing number of cancer patients, and decreasing treatment costs are key reasons for increasing market growth in the APAC region in the forecast period. Asia has nearly 49% of cancer patients compared to the world.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Emerging novel key players are concentrated on a diverse strategic policy to improve their respective businesses in foreign markets. Key players for a strong presence in the market sign strategies like mergers, collaborations, expansion, and acquisitions are anticipated to increase competition from competitors. These strategies are helping to grow the reach and quality of the product portfolios with developed expertise.

Listed below are some of the most prominent bio-based surface disinfectant industry players.

Market Key Players

• Accuray Incorporated
• Elekta AB
• GE Healthcare
• IBA Group
• Mitsubishi Electric
• Nordion Inc.
• Nucletron B.V.
• Philips Healthcare
• Sumitomo Heavy Industry Ltd
• Varian Medical Systems
• Koninklijke Philips N.V.
• Varian Medical Systems International Ag
• Toshiba Medical Systems Corporation
• Shenzhen Genemdx Biotech
• Sensus Healthcare
• Mevion Medical Systems, Inc.
• Intraop Medical
• Other Key Players

Recent Developments

• In 2022, Accuracy formed a commercial collaboration with GE Healthcare to increase access and develop precision practice radiation therapy.
• In 2020, Accuracy launched the novel Cyberknife S7 System to treat cancer for all stereotactic body radiation therapy and stereotactic radiosurgery.